Page last updated: 2024-08-24

gemcitabine and berotek

gemcitabine has been researched along with berotek in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Bernier, M; Singh, NS; Wainer, IW1

Other Studies

2 other study(ies) available for gemcitabine and berotek

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Selective GPR55 antagonism reduces chemoresistance in cancer cells.
    Pharmacological research, 2016, Volume: 111

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; beta Catenin; Biomarkers, Tumor; Carrier Proteins; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Fenoterol; Gemcitabine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Signal Transduction; Thyroid Hormone-Binding Proteins; Thyroid Hormones

2016